Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philippe Rougier

Showing results (81-90 of 144) with videos related to

Pageof 15
Sort By:
Gastroenterologie Clinique Et Biologique|January 8, 2008
Risk of venous thrombosis in patients with pancreatic adenocarcinomaEmmanuel Mitry, Raffic Taleb-Fayad, Antoine Deschamps, et al.
JAMA|May 6, 2010
Benefit of adjuvant chemotherapy for resectable gastric cancer: a meta-analysis, Xavier Paoletti, Koji Oba, et al.
Gastroenterologie Clinique Et Biologique|March 1, 2006
Longitudinal quality of life study in patients with metastatic gastric cancer. Analysis modalities and clinical applicability of QoL in randomized phase II trial in a digestive oncologyFranck Bonnetain, Olivier Bouché, Thierry Conroy, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 1, 2006
Multicenter randomized trial of adjuvant fluorouracil and folinic acid compared with surgery alone after resection of colorectal liver metastases: FFCD ACHBTH AURC 9002 trialGuillaume Portier, Dominique Elias, Olivier Bouche, et al.
The Journal of Clinical Endocrinology and Metabolism|January 15, 2009
Impact of fluorodihydroxyphenylalanine-18F positron emission tomography on management of adult patients with documented or occult digestive endocrine tumorsFrançoise Montravers, Khaldoun Kerrou, Valérie Nataf, et al.
European Journal of Cancer (Oxford, England : 1990)|December 3, 2014
Bevacizumab plus capecitabine in patients with progressive advanced well-differentiated neuroendocrine tumors of the gastro-intestinal (GI-NETs) tract (BETTER trial)--a phase II non-randomised trialEmmanuel Mitry, Thomas Walter, Eric Baudin, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|February 8, 2018
Phase III randomized trial comparing 5-fluorouracil and oxaliplatin with or without docetaxel in first-line advanced gastric cancer chemotherapy (GASTFOX study)Aziz Zaanan, Emmanuelle Samalin, Thomas Aparicio, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 22, 2015
Fluorouracil, leucovorin, and irinotecan plus cetuximab treatment and RAS mutations in colorectal cancerEric Van Cutsem, Heinz-Josef Lenz, Claus-Henning Köhne, et al.
European Journal of Gastroenterology & Hepatology|November 2, 2012
Colorectal neuroendocrine carcinomas and adenocarcinomas share oncogenic pathways. A clinico-pathologic study of 12 casesRaymond Karkouche, Jean-Baptiste Bachet, Jeremy Sandrini, et al.
Clinics and Research in Hepatology and Gastroenterology|November 20, 2012
Double pancreatic and gastric adenocarcinomas: a rare associationHampig Raphael Kourie, Nina Markoutsaki, Hélène Roussel, et al.
Pageof 15

Showing results (81-90 of 144) with videos related to

Sort By:
Pageof 15
Gastroenterologie Clinique Et Biologique|January 8, 2008
Risk of venous thrombosis in patients with pancreatic adenocarcinomaEmmanuel Mitry, Raffic Taleb-Fayad, Antoine Deschamps, et al.
JAMA|May 6, 2010
Benefit of adjuvant chemotherapy for resectable gastric cancer: a meta-analysis, Xavier Paoletti, Koji Oba, et al.
Gastroenterologie Clinique Et Biologique|March 1, 2006
Longitudinal quality of life study in patients with metastatic gastric cancer. Analysis modalities and clinical applicability of QoL in randomized phase II trial in a digestive oncologyFranck Bonnetain, Olivier Bouché, Thierry Conroy, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 1, 2006
Multicenter randomized trial of adjuvant fluorouracil and folinic acid compared with surgery alone after resection of colorectal liver metastases: FFCD ACHBTH AURC 9002 trialGuillaume Portier, Dominique Elias, Olivier Bouche, et al.
The Journal of Clinical Endocrinology and Metabolism|January 15, 2009
Impact of fluorodihydroxyphenylalanine-18F positron emission tomography on management of adult patients with documented or occult digestive endocrine tumorsFrançoise Montravers, Khaldoun Kerrou, Valérie Nataf, et al.
European Journal of Cancer (Oxford, England : 1990)|December 3, 2014
Bevacizumab plus capecitabine in patients with progressive advanced well-differentiated neuroendocrine tumors of the gastro-intestinal (GI-NETs) tract (BETTER trial)--a phase II non-randomised trialEmmanuel Mitry, Thomas Walter, Eric Baudin, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|February 8, 2018
Phase III randomized trial comparing 5-fluorouracil and oxaliplatin with or without docetaxel in first-line advanced gastric cancer chemotherapy (GASTFOX study)Aziz Zaanan, Emmanuelle Samalin, Thomas Aparicio, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 22, 2015
Fluorouracil, leucovorin, and irinotecan plus cetuximab treatment and RAS mutations in colorectal cancerEric Van Cutsem, Heinz-Josef Lenz, Claus-Henning Köhne, et al.
European Journal of Gastroenterology & Hepatology|November 2, 2012
Colorectal neuroendocrine carcinomas and adenocarcinomas share oncogenic pathways. A clinico-pathologic study of 12 casesRaymond Karkouche, Jean-Baptiste Bachet, Jeremy Sandrini, et al.
Clinics and Research in Hepatology and Gastroenterology|November 20, 2012
Double pancreatic and gastric adenocarcinomas: a rare associationHampig Raphael Kourie, Nina Markoutsaki, Hélène Roussel, et al.
Pageof 15